2 unknown, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Recruiting 1 |
Follow Multi Vessel Coronary Artery Disease: new trials by email Literature Review of Multi Vessel Coronary Artery Disease trials Research Report on Multi Vessel Coronary Artery Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator Culprit lesion only PCI, Immediate multi-vessel PCI - Cardiogenic Shock, Acute Myocardial Infarction | Phase 4 | Recruiting | Samsung Medical Center | 560 | 2022-11-16 | 2024-11-06 |
| Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass Ticagrelor, Clopidogrel - Multi Vessel Coronary Artery Disease | Phase 4 | Unknown | Yonsei University | 204 | 2022-02-01 | 2021-12-22 |
| Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Allopurinol - Diabetes Mellitus, Ischemic Heart Disease | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2018-12-01 | 2018-11-21 |
Diabetes Mellitus (1) · Myocardial Ischemia (1) · Shock, Cardiogenic (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Vascular Diseases (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Infarction (1) · Ischemia (1) · Metabolic Diseases (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Necrosis (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Shock (1)
Allopurinol (1) · Clopidogrel (1) · Ticagrelor (1)
Samsung Medical Center (1) · Tel-Aviv Sourasky Medical Center (1) · Yonsei University (1)
South Korea (2)
Jeong Hoon Yang, MD (1) · Yaron Arbel, M.D (1)